Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: an interrupted time series regression analysis

Daniel R. Morales (Lead / Corresponding author), Tatiana Macfarlane, Thomas M. MacDonald (Lead / Corresponding author), Jesper Hallas, Martin Thomsen Ernst, Ron M. C. Herings, Elisabeth Smits, Jetty A. Overbeek, Lyn Mitchell, Steven Morant, Isla Mackenzie, Alexander Doney, Chris Robertson, Marion Bennie, Li Wei, Lizzie Nicholson, Carole Morris, Robert W. F. Flynn

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)
62 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: an interrupted time series regression analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences